[Asia Economy Reporter Minji Lee] The Korea Exchange announced on the 31st that it has decided to grant a one-year improvement period following the Corporate Review Committee meeting regarding Kolon TissueGene.



The Exchange stated, "Within 15 days from the end of the improvement period, a report on the implementation of the improvement plan and an expert's verification of the implementation results must be submitted," adding, "Within 20 days from the submission date, the Corporate Review Committee will be convened to deliberate and decide on whether to delist the company."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing